(Q28377116)

1

0 references

C C Cutrì

2

0 references

A Castro

3

0 references

G Tempera

4

0 references

F Guerrera

5

0 references

M C Sarvà

6

0 references

E Geremia

Drugs against rhinoviruses

7

0 references

language of work or name

English

0 references

publication date

March 2000

0 references

published in

Antiviral Research

0 references

volume

45

0 references

issue

3

0 references

page(s)

199-210

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

In vitro activity of R 61837, a new antirhinovirus compound

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Antirhinoviral activity of heterocyclic analogs of Win 54954

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

3-methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis of new 3,4,5-trisubstituted isothiazoles as effective inhibitory agents of enteroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Antiviral activity of some .beta.-diketones. 2. Aryloxy alkyl diketones. In vitro activity against both RNA and DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Isoxazoles with antipicornavirus activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Inhibitory effects of 3-imino-5-phenyl-3H-1,2-dithiole on poliovirus type 1 replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Intranasal pirodavir (R77,975) treatment of rhinovirus colds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Oral efficacy of WIN 51711 in mice infected with human poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Inhibition of uncoating of poliovirus by arildone, a new antiviral drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Recurrent wheezy bronchitis and viral respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Respiratory viruses and exacerbations of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis and antiviral activity of sulfonamidobenzophenone oximes and sulfonamidobenzamides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

A novel basis of capsid stabilization by antiviral compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

In vitro antiviral activity of four isothiazole derivatives against poliovirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Structure of a human common cold virus and functional relationship to other picornaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Treatment of human enterovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Rhinovirus as a lower respiratory tract pathogen in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Inhibition of an Early Stage of Rhinovirus Replication by Dichloroflavan (BW683C)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021

In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900072-3

7 January 2021